These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8879380)

  • 1. Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer: a randomized phase II trial of the EORTC lung cancer cooperative group.
    Manegold C; Drings P; Pawinski A; Lentz MA; van Glabbeke M; van Zandwijk N; Bachmann P; Schnaars Y; Skacel Z; Zatloukal P; Dolensky J; Jackevicius A; Petruzelka L; Giaccone G
    Ann Oncol; 1996 Aug; 7(6):637-9. PubMed ID: 8879380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.
    Graziano SL; Valone FH; Herndon JE; Crawford J; Richards F; Rege VB; Clamon G; Green MR
    Lung Cancer; 1996 Jun; 14(2-3):315-29. PubMed ID: 8794413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
    Mantovani G; Ghiani M; Lai P; Maccio A; Dessi D; Succu G; Massa D; Curreli L; Mulas C; Esu S; Proto E; Cadeddu G; Tore G
    Oncol Rep; 1998; 5(6):1499-505. PubMed ID: 9769395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B study.
    Graziano SL; Herndon JE; Richards F; DiFino S; Modeas C; Duggan DB; Green MR
    Cancer; 1993 Jul; 72(1):62-8. PubMed ID: 8389667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study.
    Hoffman PC; Masters GA; Drinkard LC; Krauss SA; Samuels BL; Golomb HM; Vokes EE
    Ann Oncol; 1996 Mar; 7(3):314-6. PubMed ID: 8740798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma.
    Vallejo C; Romero A; Perez J; Cuevas M; Lacava J; Sabatini C; Dominguez M; Rodriguez R; Barbieri M; Romero Acuña L; Romero Acuña J; Langhi M; Amato S; Salvadori M; Ortiz E; Machiavelli M; Leone B
    Am J Clin Oncol; 1996 Dec; 19(6):584-8. PubMed ID: 8931677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral ifosfamide-mesna: a clinical investigation in advanced non-small-cell lung cancer.
    Manegold C; Bischoff H; Fischer JR; Löchner S; Peukert M; Schmähl A; Drings P
    Ann Oncol; 1992 Nov; 3(9):723-6. PubMed ID: 1333266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
    Shirinian M; Lee JS; Dhingra HH; Greenberg J; Hong WK
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):49-53. PubMed ID: 1329212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
    Wolff AC; Ettinger DS; Neuberg D; Comis RL; Ruckdeschel JC; Bonomi PD; Johnson DH
    J Clin Oncol; 1995 Jul; 13(7):1615-22. PubMed ID: 7602350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of ifosfamide combined with Mesna uroprotection in advanced non-small-cell lung carcinoma and other solid tumors.
    Nobile MT; Rosso R; Brema F; Cinquegrana A; Santi L
    Tumori; 1984 Oct; 70(5):433-7. PubMed ID: 6438851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy with ifosfamide, mitomycin, and cisplatin in advanced non-small cell lung cancer.
    Girón CG; Ordónez A; Jalón JI; Barón MG
    Cancer Treat Rep; 1987 Sep; 71(9):851-3. PubMed ID: 3040245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
    Evans WK; Stewart D; Logan D; Maroun J; Goss G; Shepherd FA; Latreille J; Warner E; Dahrouge S
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):51-6. PubMed ID: 1336622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy.
    Miller VA; Rigas JR; Pisters KM; Grant SC; Pfister DG; Heelan RT; Kris MG
    Am J Clin Oncol; 1995 Aug; 18(4):303-6. PubMed ID: 7625371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma.
    Planting AS; de Wit R; van der Burg ME; Stoter G; Verweij J
    Ann Oncol; 1996 Dec; 7(10):1080-2. PubMed ID: 9037369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifosfamide and mesna for the treatment of advanced squamous cell head and neck cancer. A GETLAC study.
    Cervellino JC; Araujo CE; Pirisi C; Francia A; Cerruti R
    Oncology; 1991; 48(2):89-92. PubMed ID: 1900124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).
    Ettinger DS; Finkelstein DM; Ritch PS; Lincoln ST; Blum RH;
    Lung Cancer; 2002 Sep; 37(3):311-8. PubMed ID: 12234701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
    Colucci G; Gebbia V; Galetta D; Riccardi F; Cariello S; Gebbia N
    Br J Cancer; 1997; 76(11):1509-17. PubMed ID: 9400950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide and mesna: response and toxicity at standard- and high-dose schedules.
    Antman KH; Elias A; Ryan L
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):68-73. PubMed ID: 2110386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial.
    Levitan N; Dowlati A; Craffey M; Tahsildar H; MacKay W; McKenney J; Remick SC
    Lung Cancer; 1998 Dec; 22(3):227-34. PubMed ID: 10048475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.